The Supreme Court is reviewing a case involving access to the abortion pill mifepristone.
While the Biden administration defends the FDA’s 2021 move to make the pill available by mail, pro-life supporters see this as a chance to rein in a ‘runaway federal agency.’
The FDA first approved mifepristone in 2000 with several conditions amid concerns about serious side effects.
“The FDA also has this drug under a black box, that is their most serious safety regulation,” said Katie Daniel, a State Policy Director with Susan B. Anthony List.
That’s because the abortion pill can cause excessive bleeding and even death.
In 2016, the FDA amended its safety conditions, extending the drug’s usage to terminate a pregnancy from 7 to 10 weeks. And in 2021, it announced doctors would no longer be required to prescribe or dispense the pill in person.
“A group of doctors have sued the FDA claiming that the restrictions that were removed in the years 2016 and 2020 not only put the safety of women and girls at risk, but it also was another usurpation of executive power,” said Attorney Sarah Parshall Perry with the Heritage Foundation.
***Please sign up for CBN Newsletters and download the CBN News app to ensure
The remainder of this article is available in its entirety at CBN